Zahra Oubihi

Zahra Oubihi has a diverse work experience in the scientific field. Zahra started their career as an Intern at Institut National d'Oncologie, where they worked on a project focused on triple-negative breast cancer and the evaluation of tumour-infiltrating lymphocytes. Zahra then joined the Kennedy Institute of Rheumatology as a Visitor, where they conducted research on the molecular regulation of neutrophils in inflammation, specifically focusing on the transcription factor interferon regulatory factor 5 (IRF5). Zahra's next role was as a Postgraduate Student at Università degli Studi di Sassari, where they pursued their studies in a scientific field. Zahra then worked as an Associate Scientist at Akamis Bio, contributing to scientific research and projects. Currently, Zahra is an Associate Scientist at Kymab Ltd, utilizing their scientific skills and knowledge in their role.

Zahra Oubihi earned a Master's degree in Biotechnology from Università degli Studi di Sassari, completing their studies between 2018 and 2021.